These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 4015743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
    Gikalov I, Radivojevich F, Schiemann O, Fenner H.
    Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The bioavailability of two commercial preparations of allopurinol tablets.
    Marcus M, Tse FL, Kleinberg SI.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):302-5. PubMed ID: 7107081
    [Abstract] [Full Text] [Related]

  • 5. [Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol].
    Rüffer C, Zorn G, Henkel E, Mitzkat HJ.
    Arzneimittelforschung; 1982 Jul; 32(9):1149-52. PubMed ID: 6890841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of dietary protein on the clearance of allopurinol and oxypurinol.
    Berlinger WG, Park GD, Spector R.
    N Engl J Med; 1985 Sep 26; 313(13):771-6. PubMed ID: 4033706
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection.
    Reinders MK, Nijdam LC, van Roon EN, Movig KL, Jansen TL, van de Laar MA, Brouwers JR.
    J Pharm Biomed Anal; 2007 Oct 18; 45(2):312-7. PubMed ID: 17890037
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid versus serum concentrations of 5-FU, allopurinol, and oxypurinol during treatment of metastatic brain cancer with 5-FU infusion, allopurinol, and radiation.
    Hornbeck CL, Floyd RA, Byfield JE, Griffiths JC, Frankel S, Sharp TR.
    Cancer Treat Rep; 1982 Mar 18; 66(3):571-3. PubMed ID: 7060045
    [No Abstract] [Full Text] [Related]

  • 17. Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol.
    Reiter S, Simmonds HA, Zöllner N, Braun SL, Knedel M.
    Clin Chim Acta; 1990 Mar 15; 187(3):221-34. PubMed ID: 2323062
    [Abstract] [Full Text] [Related]

  • 18. Allopurinol kinetics.
    Hande K, Reed E, Chabner B.
    Clin Pharmacol Ther; 1978 May 15; 23(5):598-605. PubMed ID: 639435
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.